Treatment of Acinetobacter Infections - Clinical Infectious Diseases Acinetobacter baumannii remains an important and difficult-to-treat pathogen .... The efficacy of inhaled antibiotics, including aminoglycosides, outside the cystic ...
Johns Hopkins Guides: Acinetobacter baumannii 15 Nov 2011 ... Acinetobacter baumannii answers are found in the Johns Hopkins Antibiotic ( ABX) Guide -- online and for download to iPhone, iPad, Android, ...
Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phen the nonsusceptibility rate of sulbactam in A baumannii was Table 1 The number and percentage of isolates identified as Acinetobacter baumannii complex from blood samples ...
Treatment of Acinetobacter Infections - Oxford Journals | Medicine & Health | Clinical Infectious Di Acinetobacter baumannii has proven to be an increasingly important and demanding species in health care-associated infections. ... Mixed results have been reported for use of sulbactam to treat A. baumannii meningitis, and this likely relates to impaired
Sulbactam-based therapy for Acinetobacter baumannii infection 2013年4月18日 - A number of studies have reported on the effectiveness of sulbactam-based therapies ...
Drug Treatment for Multidrug-resistant Acinetobacter ... The combination of sulbactam and carbapenems on MDR A. baumannii infection has been investigated ...
High-dose ampicillin-sulbactam as an alternative treatment of ... The increased incidence of multidrug-resistant (MDR) Acinetobacter baumannii ventilator-associated ...
Efficacy of sulbactam alone and in combination with ampicillin ... Of the 42 patients, 39 improved or were cured and showed A. baumannii eradication and one patient ...
Severe nosocomial infections with imipenem-resistant ... ... infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Sulbactam efficacy in experimental models caused by ... These results show the efficacy of sulbactam in infections caused by susceptible strains of A. baumannii, ...
